Emerald Advisers »

Palvella Therapeutics Inc Ne shares owned by Emerald Advisers

Quarter-by-quarter ownership of Palvella Therapeutics Inc Ne (PVLA) shares owned by Emerald Advisers from 13F filings

Historical chart of Emerald Advisers investment in Palvella Therapeutics Inc Ne

Tip: Access up to 7 years of quarterly data

All positions including Palvella Therapeutics Inc Ne held by Emerald Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palvella Therapeutics Inc Ne by Emerald Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $20M 162k 124.65

More positions owned by Emerald Advisers

Modine Manufacturing (MOD)
Guardant Health (GH)
Bloom Energy Corp (BE)
TTM Technologies (TTMI)
Cogent Biosciences (COGT)
Kratos Defense & Security Solutions (KTOS)
VSE Corporation (VSEC)
Fabrinet (FN)
Argan (AGX)
Aar (AIR)
Credo Technology Group Holding (CRDO)
Travere Therapeutics (TVTX)
ESCO Technologies (ESE)
Mercury Computer Systems (MRCY)
Livanova Plc Ord (LIVN)

View all positions for Emerald Advisers

Top funds holding Palvella Therapeutics Inc Ne

Suvretta Capital Management
First Light Asset Management
BVF
Frazier Life Sciences Management
BlackRock
Jennison Associates
Vanguard Group
Vanguard Capital Management
Federated Investors
State Street Corporation
Summit Partners Public Asset Management
Woodline Partners
Alliancebernstein
FMR
MPM Oncology Impact Management

View all funds holding Palvella Therapeutics Inc Ne